Radiation Barrier

  • Home
  • Radiation Barrier

Radiation Barrier Radiation Barrier is dedicated to improving the cost, quality and effectiveness of cancer treatments, for patients, doctors, and insurers.

Radiation Barrier is an Adaptive Immunotherapy company that addresses the unmet need of cancer treatment toxicity in combination with standard and personalized cancer treatment. Dr. Richard Blankenbecler, a world-renowned professor of Theoretical Physics at Stanford University’s SLAC National Accelerator Laboratory, developed and patented the process to activate latent genes that combat the toxic

side effects of cancer treatment with a specific low-dose radiation protocol. His discoveries and patents are based on $250 Million dollars of research over 16 years, sponsored by the U.S. Department of Energy’s Office of Science, Low Dose Radiation Research program. The DOE research indicates that low levels of radiation are not only safe, but beneficial to humans. In fact, recent research indicates that background radiation may even be necessary for life. At low doses of radiation, all organisms have cellular repair and response mechanisms that can keep adverse health effects from occurring, something that has evolved as life evolved (PNAS 2011). Radiation Barrier was conceived when Dr. Blankenbecler applied this knowledge to solve untreated medical dilemmas.

Address


Website

Alerts

Be the first to know and let us send you an email when Radiation Barrier posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Radiation Barrier:

Shortcuts

  • Address
  • Alerts
  • Contact The Practice
  • Claim ownership or report listing

  • Want your practice to be the top-listed Clinic?

Share